CommercialAdministrativeLow impact
07.11.02f, Measurement of Exhaled Nitric Oxide and Breath Condensate in the Diagnosis and Management of Asthma and Other Respiratory Disorders
Independence Blue Cross·Pulmonology, Family Medicine, Internal Medicine +1 more·Medical Policy
We identified it
Jun 19, 2026
Summary
This is a routine annual reissue of the Independence Blue Cross exhaled nitric oxide policy with no substantive changes to coverage criteria. The policy maintains coverage for eNO testing in asthma diagnosis and management (limited to 5 tests per 12 months) while continuing to classify exhaled breath condensate testing as experimental/investigational and not covered.
Action Required
No immediate action required. This is a reissue with no changes to the existing policy. Billing team should verify that current claim editing rules for CPT 95012 (covered, max 5 per 12 months for asthma) and CPT 83987 (not covered, experimental) remain in place. No workflow modifications are necessary.